Showing results (131-140 of 198) with videos related to
Sort By:
Pageof 20
Reproductive Toxicology (Elmsford, N.Y.)|January 17, 2021
Macrolide and lincosamide antibiotic exposure in the first trimester of pregnancy and risk of congenital anomaly: A European case-control studyAminkeng Zawuo Leke, Helen Dolk, Maria Loane, et al.Lancet (London, England)|October 6, 2025
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trialDavid J Lewis, Mats Jerkeman, Lexy Sorrell, et al.Paediatric and Perinatal Epidemiology|August 26, 2017
Gastroschisis in Europe - A Case-malformed-Control Study of Medication and Maternal Illness during Pregnancy as Risk FactorsJoanne E Given, Maria Loane, Ester Garne, et al.European Journal of Medical Genetics|May 14, 2018
Prevalence of valproate syndrome in Europe from 2005 to 2014: A registry based multi-centre studyJoan K Morris, Ester Garne, Maria Loane, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|February 29, 2012
Spectrum of congenital anomalies in pregnancies with pregestational diabetesEster Garne, Maria Loane, Helen Dolk, et al.European Journal of Human Genetics : EJHG|January 9, 2014
Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum: a registry-based study in EuropeIngeborg Barisic, Ljubica Odak, Maria Loane, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|March 19, 2014
Seasonality of congenital anomalies in EuropeJohannes Michiel Luteijn, Helen Dolk, Marie-Claude Addor, et al.European Journal of Clinical Pharmacology|February 26, 2025
Antiretroviral drug exposure in pregnancy and risk of congenital anomalies: a European case/non-case malformed studyLaura Saint-Lary, Anna-Belle Beau, Agnès Sommet, et al.Birth Defects Research. Part A, Clinical and Molecular Teratology|June 16, 2016
Use of hierarchical models to analyze European trends in congenital anomaly prevalenceAlana Cavadino, David Prieto-Merino, Marie-Claude Addor, et al.The New England Journal of Medicine|June 21, 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphomaMichael L Wang, Simon Rule, Peter Martin, et al.Pageof 20